Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep1221 | Clinical Cases–Pituitary/Adrenal | ECE2015

Two treatment patterns of thyrotropinomas with over 3-year follow-up

Coculescu Mihail , Vintila Madalina

Introduction: Thyrotropinomas are rare pituitary tumours. Neurosurgery is considered the first-line treatment, followed by medical therapy with somatostatin analogues or radiotherapy.Case reports: We present two cases of thyrotropinomas with different therapeutic approaches. Case 1: A 63-year old man presented with severe thyrotoxicosis. Biochemical evaluation showed inappropriate TSH secretion (TSH=7.5 mU/l, FT4=45.5 pmol/l); computed tomogra...

ea0021p98 | Clinical practice/governance and case reports | SFEBES2009

Challenges in management of aggressive GH secreting tumors in adolescents

Verzea Simona , Vintila Madalina , Badiu Corin

Despite rarer in children than in adults, GH-secreting pituitary adenomas are often more aggressive, being challenging cases during childhood. Somatic changes (tall stature and acromegalic features), optic chiasma syndrome or metabolic and cardiovascular impact of GH excess trigger diagnosis and requires aggressive management. Treatment options are surgery, radiotherapy and medical therapy using somatostatin analogues, dopamine agonists and recently, GH receptor antagonists &#...

ea0049ep352 | Paediatric endocrinology | ECE2017

Progressive osseous heteroplasia in a child with pseudohypoparathyroidism type I

Vintila Madalina , Gherlan Iuliana , Dumitrescu Cristina , Dumitrascu Anda , Procopiuc Camelia

Introduction: Progressive osseous heteroplasia (POH) is a rare genetic condition of progressive heterotopic ossification (HO), from skin and subcutaneous tissues into deep skeletal muscles. Most cases are caused by heterozygous inactivating mutations of GNAS gene. Related disorders are Albright hereditary osteodystrophy (AHO), pseudohypoparathyroidism (PHP), and primary osteoma cutis. Distinction from other GNAS-based conditions is made by the extension of HO from superficial ...

ea0038p374 | Reproduction | SFEBES2015

A rare form genetic abnormality in Turner syndrome

Costache-Outas Mariana-Cristina , Procopiuc Camelia , Popa Oana , Vintila Madalina-Aura , Costache Cosmina-Raluca , Stambouli Danai

Turner Syndrome (TS) is defined as the combination of characteristic physical features in phenotypic females and complete or partial absence of the second sex chromosome. Short stature is a constant clinical finding in patients with TS. We report the case of a 18 year old female with TS and normal stature. Primary amenorrhea was the reason for the first clinical presentation. Laboratory evaluation showed hypergonadotropic hypogonadism, low oestrogens and testosterone. A pelvic...

ea0031p259 | Pituitary | SFEBES2013

Short-term (3 months) compared to long-term response to somatostatin analogues in acromegaly

Gheorghiu Monica Livia , Vintila Madalina , Purice Mariana , Poiana Catalina , Coculescu Mihai

Objective: To evaluate whether serum GH and IGF1 levels achieved after 3 months treatment with somatostatin analogues (SSA) are concordant with the efficacy of SSA after longer treatment with the same dose.Patients and methods: From 71 patients with acromegaly treated with SSA in our clinic, in 38 of them (28 women, 10 men, aged 22–62 years) data on serum GH and IGF1 were available at baseline, after 3 months and at the last evaluation on the same S...

ea0050p333 | Obesity and Metabolism | SFEBES2017

Genes involved in zinc homeostasis are associated with metabolic syndrome and insulin resistance in Romanian and French populations

Ilie Mirela Diana , Haydar Sara , Vintila Madalina , Lautier Corinne , Normand Christophe , Gheorghiu Monica , Poiana Catalina , Badiu Corin , Grigorescu Florin

Introduction: Zinc homeostasis is involved in numerous physiological and pathological conditions, ranging from type 1 and type 2 diabetes to memory impairment and cancer, and is determined by at least 28 genes, including 24 SLC (Solute Carrier) family members and 4 MTs (Metallothioneins). To explore the potential role of zinc homeostasis in MetS (metabolic syndrome) and IR (insulin resistance), we investigated 28...

ea0050p333 | Obesity and Metabolism | SFEBES2017

Genes involved in zinc homeostasis are associated with metabolic syndrome and insulin resistance in Romanian and French populations

Ilie Mirela Diana , Haydar Sara , Vintila Madalina , Lautier Corinne , Normand Christophe , Gheorghiu Monica , Poiana Catalina , Badiu Corin , Grigorescu Florin

Introduction: Zinc homeostasis is involved in numerous physiological and pathological conditions, ranging from type 1 and type 2 diabetes to memory impairment and cancer, and is determined by at least 28 genes, including 24 SLC (Solute Carrier) family members and 4 MTs (Metallothioneins). To explore the potential role of zinc homeostasis in MetS (metabolic syndrome) and IR (insulin resistance), we investigated 28...

ea0049ep206 | Paediatric endocrinology | ECE2017

Congenital adrenal hyperplasia: impact of therapy on growth and sexual maturation – a 5-year retrospective study of a Tertiary Pediatric Endocrinology Center

Procopiuc Camelia , Vintila Madalina , Gherlan Iuliana , Cirla Amel , Brehar Andreea , Caragheorgheopol Andra , Popa Suzana Vladoiu Oana , Dumitrescu Cristina

Objective: To evaluate the comparative effects of different glucocorticoid treatments on growth and sexual maturation in patients with congenital adrenal hyperplasia.Patients and methods: We conducted a retrospective observational cohort study in 78 patients (60 girls, 18 boys) diagnosed with congenital adrenal hyperplasia (CAH), followed-up for a period of 5 years. The majority had 21-hydroxylase deficiency (75 patients), 2 had 11-β hydroxylase def...

ea0090ep11 | Adrenal and Cardiovascular Endocrinology | ECE2023

Carriers of a pathological variant in CYP21A2 gene– clinical and hormonal status

Schipor Sorina , Procopiuc Camelia , Stancu Cristina , Vintila Madalina , Brehar Andreea Cristiana , Muresan Andrei , Manda Dana , Caragheorgheopol Andra , Elena Dumitrica Alina , Udrea Luminita , Vladoiu Suzana , Gherlan Iuliana

Introduction: 21-hydroxylase deficiency (21OHD) is an autosomal recessive disorder and the diagnosis is confirmed by the presence of at least two biallelic pathogenic variants. The phenotype is determined by the less deleterious variant. The relevance of hormonal assessment to distinguish between heterozygote carriers of pathologic mutations and non-carriers or genetically defined 21OHD patients is still a matter of debate. Identifying the heterozygous genotype is important in...